Abstract
Autoantibody tests are often ordered inappropriately. We aimed to evaluate the ordering patterns of these tests in our local health region and to develop a laboratory algorithm aimed at reducing unnecessary tests. Laboratory data including the number and sequence of tests, ordering physician specialties and results for antinuclear (ANA), extractable nuclear antigen (ENA) and anti-double stranded DNA (anti-dsDNA) antibody tests from 2007 to 2009 were evaluated. Based on this information and a clinical consensus meeting, an algorithm was developed and applied retrospectively to 1 year of inpatient laboratory data to simulate potential cost savings. We identified a large volume of these autoantibody tests performed, equating to testing costs of $862,706.72, where less than 17 % of each were positive. Repeated ANA tests were mostly ordered after a previously negative result, and 1 % of patients with negative results changed to ≥1:160 on repeat testing. Close to half of all ENA and anti-dsDNA tests that were ordered were done so simultaneously with ANA, suggesting their use as screening tests. This was done more frequently in the inpatient setting. An algorithm was developed where ENA and anti-dsDNA tests would be cancelled if ANA was negative in the same sample. ANA repeated within 1 year would be cancelled and the prior result provided. Application of the algorithm retrospectively simulated a 30 % cost savings. Repeat testing and simultaneous ordering of multiple tests contributed to the excessive ordering of autoantibody tests in our health region. Our proposed algorithm would reduce testing costs and should be accompanied by appropriate educational information for physicians.
Similar content being viewed by others
References
Tan EM, Feltkamp TE, Smolen JS et al (1997) Range of antinuclear antibodies in “healthy” individuals. Arthritis Rheum 40(9):1601–1611
Tampoia M, Brescia V, Fontana A et al (2007) Application of a combined protocol for rational request and utilization of antibody assays improves clinical diagnostic efficacy in autoimmune rheumatic disease. Arch Pathol Lab Med 131(1):112–116
Solomon DH, Shmerling RH, Schur PH et al (1999) A computer based intervention to reduce unnecessary serologic testing. J Rheumatol 26(12):2578–2584
Bonaguri C, Melegari A, Dall’Aglio P et al (2009) An Italian multicenter study for application of a diagnostic algorithm in autoantibody testing. Ann N Y Acad Sci 1173:124–129
Wiik A, Cervera R, Haass M et al (2006) European attempts to set guidelines for improving diagnostics of autoimmune rheumatic disorders. Lupus 15(7):391–396
Tozzoli R, Bizzaro N, Tonutti E et al (2002) Guidelines for the laboratory use of autoantibody tests in the diagnosis and monitoring of autoimmune rheumatic diseases. Am J Clin Pathol 117(2):316–324
Stinton LM, Fritzler MJ (2007) A clinical approach to autoantibody testing in systemic autoimmune rheumatic disorders. Autoimmun Rev 7(1):77–84
Kavanaugh A, Tomar R, Reveille J, Solomon DH, Homburger HA (2000) Guidelines for clinical use of the antinuclear antibody test and tests for specific autoantibodies to nuclear antigens. American College of Pathologists. Arch Pathol Lab Med 124(1):71–81
Shojania K (2000) Rheumatology: 2. What laboratory tests are needed? CMAJ 162(8):1157–1163
Bizzaro N, Wiik A (2004) Appropriateness in anti-nuclear antibody testing: from clinical request to strategic laboratory practice. Clin Exp Rheumatol 22(3):349–355
Anon. (2001) Guidelines and protocols advisory committee—antinuclear antibody (ANA) testing for connective tissue disease. http://www.bcguidelines.ca/guideline_ana_testing.html. Accessed June 4, 2012.
Solomon DH, Kavanaugh AJ, Schur PH (2002) Evidence-based guidelines for the use of immunologic tests: antinuclear antibody testing. Arthritis Rheum 47(4):434–444
Avina-Zubieta JA, Sayre EC, Bernatsky S et al (2011) Adult Prevalence of Systemic Autoimmune Rheumatic Diseases (SARDs) in British Columbia. Can Arthritis Rheum 63(Suppl 10):1846
Anon. (2012) Population estimates, British Columbia and sub-provincial—BC stats. http://www.bcstats.gov.bc.ca/StatisticsBySubject/Demography/PopulationEstimates.aspx. Accessed May 21, 2012.
Anon. (2012) Medical Services Plan home page. http://www.health.gov.bc.ca/msp/. Accessed July 24, 2012.
Wiik AS (2005) Anti-nuclear autoantibodies: clinical utility for diagnosis, prognosis, monitoring, and planning of treatment strategy in systemic immunoinflammatory diseases. Scand J Rheumatol 34(4):260–268
Dahle C, Skogh T, Aberg AK, Jalal A, Olcén P (2004) Methods of choice for diagnostic antinuclear antibody (ANA) screening: benefit of adding antigen-specific assays to immunofluorescence microscopy. J Autoimmun 22(3):241–248
Peene I, Meheus L, Veys E, De Keyser F (2001) Detection and identification of antinuclear antibodies (ANA) in a large and consecutive cohort of serum samples referred for ANA testing. Ann Rheum Dis 60(12):1131–1136
Damoiseaux JGMC, Tervaert JWC (2006) From ANA to ENA: how to proceed? Autoimmun Rev 5(1):10–17
Fritzler MJ, Miller BJ (1995) Detection of autoantibodies to SS-A/Ro by indirect immunofluorescence using a transfected and overexpressed human 60 kD Ro autoantigen in HEp-2 cells. J Clin Lab Anal 9(3):218–224
Fritzler MJ, Wiik A, Fritzler ML, Barr SG (2003) The use and abuse of commercial kits used to detect autoantibodies. Arthritis Res Ther 5(4):192–201
Meroni PL, Schur PH (2010) ANA screening: an old test with new recommendations. Ann Rheum Dis 69(8):1420–1422
Acknowledgments
We thank the participants of the clinical consensus group for their contribution towards the direction of the study and development of the laboratory algorithm: Dr. Antonio Avina-Zubieta, Dr. Kenneth Blocka, Dr. David Ferguson, Dr. Bradley Fritz, Dr. Manstein Kan, Dr. Barry Koehler, Dr. Michael Moss, Dr. Michael Nimmo, Dr. Tom Perry, Dr. Ross Petty, Dr. Robert Schellenberg and Dr. Asa Wong.
Disclosures
None.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
ESM 1
(DOC 58 kb)
Rights and permissions
About this article
Cite this article
Man, A., Shojania, K., Phoon, C. et al. An evaluation of autoimmune antibody testing patterns in a Canadian health region and an evaluation of a laboratory algorithm aimed at reducing unnecessary testing. Clin Rheumatol 32, 601–608 (2013). https://doi.org/10.1007/s10067-012-2141-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-012-2141-y